Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent β-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity

References

• Makroo RN, Agrawal S, Bhatia A, et al. Impact of antigenic exposures and role of molecular blood grouping in enhancing transfusion safety in chronically transfused thalassemics. Asian J Transfus Sci. 2016;10(2):140–144.
   PubMedGoogle Scholar
• Patel AS, Gamit S, Gohil M. Role of RBC’s alloimmunization in multiple transfused thalassaemia patients. Int J Res Med Sci. 2016;4(3):822–828.
   Google Scholar
• Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sang. 2014;106(3):197–208.
   PubMed Web of Science ®Google Scholar
• Reid ME, Hipsky CH, Hue-Roye K, et al. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Blood Cells Mol Dis. 2014;52(4):195–202.
   PubMed Web of Science ®Google Scholar
• Jain R, Choudhury N, Chudgar U, et al. Detection and identification of red cell alloantibodies in multiply transfused thalassemia major patients: a prospective study. Indian J Hematol Blood Transfus. 2014;30(4):291–296.
   PubMed Web of Science ®Google Scholar
• Thompson AA, for the Thalassemia Clinical Research Network Investigators, Cunningham MJ, Singer ST, et al. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011;153(1):121–128.
   PubMed Web of Science ®Google Scholar
• Chou ST, Liem RI, Thompson AA. Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol. 2012;159(4):394–404.
   PubMed Web of Science ®Google Scholar
• Khan J, Delaney M. Transfusion support of minority patients: extended antigen donor typing and recruitment of minority blood donors. Transfus Med Hemother. 2018;45(4):271–275.
   PubMed Web of Science ®Google Scholar
• Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev. 2016;30(4):197–201.
   PubMed Web of Science ®Google Scholar
• Dorgalaleh A, Gholami MS, Shokuhiyan M, et al. Alloimmunization against Rh and Kell blood groups antigens is the main obstacle for blood transfusion in transfusion dependent thalassemia patients in Iran. IJCRI. 2017;8(5):358–363.
   Google Scholar
• Darvishi P, Azami M, Sayehmiri K, et al. Red blood cell alloimmunization in Iranian β thalassemia patients: a systematic review and meta analysis. ISBT Sci Ser. 2016;11(3):163–173.
   Google Scholar
• Habibzadeh F, Yadollahie M, Merat A, et al. Thalassemia in Iran: an overview. Arch Iran Med. 1998;1(1):27–33.
   Google Scholar
• Zafari M, Kosaryan M. Marriage and child bearing in patients with transfusion dependent thalassemia major. J Obstet Gynaecol Res. 2014;40(8):1978–1982.
   PubMed Web of Science ®Google Scholar
• Compernolle V, for the International Collaboration for Transfusion Medicine Guidelines, Chou ST, Tanael S, et al. Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline. Transfusion. 2018;58(6):1555–1566.
   PubMed Web of Science ®Google Scholar
• El Kababi S, Benajiba M, El Khalfi B, et al. Red blood cell alloimmunizations in β-thalassemia patients in Casablanca/Morocco: prevalence and risk factors. Transfus Clin Biol. 2019;26(4):240–248.
   PubMed Web of Science ®Google Scholar
• Casas J, Friedman DF, Jackson T, et al. Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease. Transfusion. 2015;55(6pt2):1388–1393.
   PubMed Web of Science ®Google Scholar
• Castro O, Sandler SG, Houston-Yu P, et al. Predicting the effect of transfusing only phenotype matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion. 2002;42(6):684–690.
   PubMed Web of Science ®Google Scholar
• Franchini M, Forni GL, Marano G, et al. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review. Blood Transfus. 2019;17(1):4–15.
   PubMed Web of Science ®Google Scholar
• Al Riyami AZ, Al Muqbali A, Al Sudiri S, et al. Risks of red blood cell alloimmunization in transfusion dependent β thalassemia in Oman: a 25 year experience of a university tertiary care reference center and a literature review. Transfusion. 2018;58(4):871–878.
   PubMed Web of Science ®Google Scholar
• Chou S. Red blood cell antigen genotyping for haemoglobinopathies: considerations for thalassaemia and sickle cell disease. ISBT Sci Ser. 2018;13(3):238–243.
   Google Scholar
• Azarkeivan A, Ahmadi MH, Zolfaghari S, et al. RBC alloimmunization and double alloantibodies in thalassemic patients. Hematology. 2015;20(4):223–227.
   PubMed Web of Science ®Google Scholar
• Azarkeivan A, Ansari S, Ahmadi MH, et al. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatr Hematol Oncol. 2011;28(6):479–485.
   PubMed Web of Science ®Google Scholar
• Davari K, Soltanpour MS. Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients. Asian J Transfus Sci. 2016;10(1):88–92.
   PubMedGoogle Scholar
• Davoudi-Kiakalayeh A, Mohammadi R, Pourfathollah AA, et al. Alloimmunization in thalassemia patients: new insight for healthcare. Int J Prev Med. 2017;8(1):101.
   PubMedGoogle Scholar
• Ghasemi A, Abbasian S, Ghaffari K, et al. Prevalence of alloantibodies and autoantibodies in transfusion dependent thalassemia patients. IJBC. 2016;8(3):80–85.
   Google Scholar
• Hiradfar A, Keikhai B, Pedram M. Determination of clinical prevalence and predominant pattern of rbcs alloimmunization among transfusion dependent thalassemic patients in Ahvaz. Jundishapur Sci Med J. 2010;5(68):449–456.
   Google Scholar
• Karimi M, Nikrooz P, Kashef S, et al. RBC alloimmunization in blood transfusion dependent β thalassemia patients in southern Iran. Int J Lab Haematol. 2007;29(5):321–326.
   PubMed Web of Science ®Google Scholar
• Kosaryan M, Mahdavi M, Hojjati M, et al. Prevalence of alloimmunization in major β thalassemia in northern Iran (2010). J Gorgan Univ Med Sci. 2014;16(3):76–79.
   Google Scholar
• Sadeghian MH, Keramati MR, Badiei Z, et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci. 2009;3(2):95–98.
   PubMedGoogle Scholar
• Shamsian BS, Arzanian MT, Shamshiri AR, et al. Frequency of red cell alloimmunization in patients with β-major thalassemia in an Iranian referral hospital. Iran J Pediatr. 2008;18(2):149–153.
   Web of Science ®Google Scholar
• Tahannejad-Asadi Z, Elahi A, Mohseni A, et al. Screening and identifying of erythrocyte alloantibodies in patients with thalassemia major referred to Ahvaz Shafa hospital. Feyz. 2013;17(2):165–172.
   Google Scholar
• Vaziri M, JavadzadehShahshahani H, Moghaddam M, et al. Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd. Iran J Ped Hematol Oncol. 2015;5(2):93–99.
   PubMed Web of Science ®Google Scholar
• Sunassee A, Mackey J, Anderson KA, et al. Acute hemolytic transfusion reaction due to anti-Kpa antibody. S D Med. 2018;71(5):222–223.
   PubMedGoogle Scholar
• Padmore R, Berardi P, Erickson K, et al. Acute extravascular hemolytic transfusion reaction due to anti-Kpa antibody missed by electronic crossmatch. Transfus Apher Sci. 2014;51(2):168–171.
   PubMed Web of Science ®Google Scholar
• Amin M, Gholamhossein T, Majid N, et al. Prevalence of alloimmunization against RBC antigens in thalassemia major patients in South East of Iran. J Blood Disorders Transfus. J Blood Disorders Transf. 2013;4:4.
   Google Scholar